Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pfizer and Oncogene characterize EGF receptor TK inhibitor

May 13, 1997

Preliminary clinical results for LMB-2

May 13, 1997

Trimidox enhances effects of doxorubicin in vivo

May 13, 1997

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

Retinoid-like compounds that induce apoptosis in cancer cells

May 12, 1997

Glycan-conjugated 5-FU for the treatment of hepatocellular cancer/metastases

May 12, 1997

Taiho discovers potent and selective cdc25PTP inhibitors

May 12, 1997

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...